152 related articles for article (PubMed ID: 38697818)
1. Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer.
Švecová M; Fiedlerová K; Mareková M; Dubayová K
Klin Onkol; 2024; 38(2):102-109. PubMed ID: 38697818
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in endometrial cancer diagnosis: A systematic review.
Raffone A; Troisi J; Boccia D; Travaglino A; Capuano G; Insabato L; Mollo A; Guida M; Zullo F
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1135-1146. PubMed ID: 32180221
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
7. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive approaches for the early detection of endometrial cancer.
Shen Y; Yang W; Liu J; Zhang Y
Mol Cancer; 2023 Mar; 22(1):53. PubMed ID: 36932368
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers of endometrial carcinoma detected in uterine aspirates.
Colas E; Perez C; Cabrera S; Pedrola N; Monge M; Castellvi J; Eyzaguirre F; Gregorio J; Ruiz A; Llaurado M; Rigau M; Garcia M; Ertekin T; Montes M; Lopez-Lopez R; Carreras R; Xercavins J; Ortega A; Maes T; Rosell E; Doll A; Abal M; Reventos J; Gil-Moreno A
Int J Cancer; 2011 Nov; 129(10):2435-44. PubMed ID: 21207424
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches to early detection of endometrial cancer.
Bagaria M; Shields E; Bakkum-Gamez JN
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):40-46. PubMed ID: 27861202
[TBL] [Abstract][Full Text] [Related]
13. The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery.
Troisi J; Mollo A; Lombardi M; Scala G; Richards SM; Symes SJK; Travaglino A; Neola D; de Laurentiis U; Insabato L; Di Spiezio Sardo A; Raffone A; Guida M
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139068
[TBL] [Abstract][Full Text] [Related]
14. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
15. Identification of different body fluids through novel deep blue autofluorescence.
Rathore PS; Kumar S
Forensic Sci Int; 2021 Oct; 327():110976. PubMed ID: 34478895
[TBL] [Abstract][Full Text] [Related]
16. Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.
Chen J; Liu J; Cao D
BMC Womens Health; 2023 Nov; 23(1):583. PubMed ID: 37940929
[TBL] [Abstract][Full Text] [Related]
17. A metabolomic signature of FIGO stage I and II endometrial cancer.
Gu M; Chen X; Sun Y; Wang L; Shu H; Qian C
Neoplasma; 2021 Nov; 68(6):1283-1291. PubMed ID: 34689564
[TBL] [Abstract][Full Text] [Related]
18. Advances in endometrial cancer protein biomarkers for use in the clinic.
Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
[TBL] [Abstract][Full Text] [Related]
19. New perspectives on screening and early detection of endometrial cancer.
Costas L; Frias-Gomez J; Guardiola M; Benavente Y; Pineda M; Pavón MÁ; Martínez JM; Climent M; Barahona M; Canet J; Paytubi S; Salinas M; Palomero L; Bianchi I; Reventós J; Capellà G; Diaz M; Vidal A; Piulats JM; Aytés Á; Ponce J; Brunet J; Bosch FX; Matias-Guiu X; Alemany L; de Sanjosé S;
Int J Cancer; 2019 Dec; 145(12):3194-3206. PubMed ID: 31199503
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
